Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/28938| Title: | Cluster headache in adults. | Austin Authors: | Ray, Jason C ;Stark, Richard J;Hutton, Elspeth J | Affiliation: | Department of Neurology, Alfred Hospital, Melbourne, Victoria, Australia.. Neurology Department of Neuroscience, Monash University, Melbourne, Victoria, Australia.. .. |
Issue Date: | Feb-2022 | Date: | 2022 | Publication information: | Australian prescriber 2022; 45(1): 15-20 | Abstract: | Cluster headache is characterised by attacks of very severe, unilateral headache lasting 15-180 minutes, up to eight times per day. The attacks are associated with cranial autonomic symptoms on the same side and a sense of agitation or restlessness First-line acute abortive treatments include intranasal or subcutaneous sumatriptan or high-flow oxygen. Neuromodulation may benefit some patients First-line preventive therapy is high-dose verapamil. Close monitoring is required for the adverse effect of arrhythmia There are several emerging therapies that have either proven efficacy, or possible benefit for cluster headache. They include drugs aimed at the calcitonin gene-related peptide. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/28938 | DOI: | 10.18773/austprescr.2022.004 | ORCID: | https://orcid.org/0000-0003-4833-5507 https://orcid.org/0000-0002-8543-7767 https://orcid.org/0000-0002-1637-9700 |
Journal: | Australian prescriber | PubMed URL: | 35233134 | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/35233134/ | ISSN: | 0312-8008 | Type: | Journal Article | Subjects: | calcitonin gene-related peptide cluster headache trigeminal autonomic cephalalgias triptans |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.